What is the clinical evidence from this study?

Study design: Review. Population: High blood pressure. Intervention: Antihypertensive drugs.

What question did this study set out to answer?

To review the evolution of hypertension management recommendations across Joint National Committee reports and examine national trends in blood pressure control and cardiovascular mortality.

November 24, 1997Archives of Internal Medicine

Evolution of the Joint National Committee Reports, 1988-1997

View Full Paper

Ask AI

Bookmark

Key result

The JNC VI report documents major progress in antihypertensive drug availability, though improvements in hypertension detection, treatment, and control rates plateaued between 1991 and 1994.

Population

Individuals with high blood pressure

Design

Review

Authors

TFTimothy C. FaganUniversity of Arizona

Discussion

Member takes

Implication

Stagnant hypertension control rates after 1991 warrant renewed clinical vigilance; this review leaves open reasons for the plateau despite expanded therapies.

Key Points

To review the evolution of hypertension management recommendations across Joint National Committee reports and examine national trends in blood pressure control and cardiovascular mortality.
Evaluated historical guideline updates and pharmacological advancements spanning from JNC IV (1988) to JNC VI (1997).
Assessed population-level trends in hypertension identification, treatment, and control rates alongside stroke and coronary heart disease mortality from 1976 to 1994.
Hypertension identification, treatment, and control improved steadily from 1976 through 1991, paralleled by substantial decreases in stroke and coronary heart disease mortality.
Rates of detection, treatment, and blood pressure control stalled between 1991 and 1994, coinciding with a plateau in mortality declines for stroke and coronary heart disease.
Therapeutic options expanded significantly over this period, encompassing five broad antihypertensive drug classes comprising 47 distinct agents by JNC IV with further class advancements documented in JNC VI.

Structured PICO

Population

Individuals with high blood pressure

Exposure

Antihypertensive treatment based on Joint National Committee (JNC) reports

Outcome

Rates of detection, treatment, and control of high blood pressure, and death from stroke and coronary heart disease

The report highlights the historical progress and subsequent plateau in hypertension management and cardiovascular mortality reduction in the early 1990s.

Cite This Study

Timothy C. Fagan (1997) conducted a review in High blood pressure. Antihypertensive drugs was evaluated. The JNC VI report documents major progress in antihypertensive drug availability, though improvements in hypertension detection, treatment, and control rates plateaued between 1991 and 1994.

synapsesocial.com/papers/6a93cbc81c98c85e85563d87 https://doi.org/10.1001/archinte.1997.00440420019002

Topics

Hypertension management

View Full Paper

Ask AI

Bookmark

Implication

Stagnant hypertension control rates after 1991 warrant renewed clinical vigilance; this review leaves open reasons for the plateau despite expanded therapies.

Evolution of the Joint National Committee Reports, 1988-1997

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Topics

Evolution of the Joint National Committee Reports, 1988-1997

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Also Consider

Topics

Also Consider